Michael Anstey is a Partner at Cambridge Innovation Capital, where they have been since 2017. Previously, they served as a Principal at The Boston Consulting Group from 2010 to 2017 and co-founded Proteorex Therapeutics Inc. from 2014 to 2018. Michael has held various board roles at companies such as Bicycle Therapeutics, Epitopea, Sense Biodetection Ltd, and Congenica. They earned a DPhil from the University of Oxford and completed the Kauffman Fellowship in 2019.
Location
Cambridge, United Kingdom
This person is not in any teams